Roche (Malaysia) Sdn Bhd, the pharmaceutical division, and Roche Diagnostics (M) Sdn Bhd, the diagnostics division, have recently inked a memorandum of understanding (MoU) with Premier Integrated Labs (PILs) to enhance awareness and accessibility of Comprehensive Genomic Profiling (CGP) for patients in Malaysia.
Comprehensive Genomic Profiling (CGP) is a personalized approach to cancer treatment. With a single test, CGP can analyze a wide array of genes known to drive cancer growth. This type of testing generates comprehensive patient reports, offering in-depth insights into potential underlying cancer drivers.
Heng Chai Yin, general manager of Roche Diagnostics (M) Sdn. Bhd., said, “At Roche,
we have a passion for innovation and we strive to improve patient access in Malaysia as
healthcare that is built on people’s needs, strong data and clinical insights is healthcare that saves lives.”
She noted that Roche understands the importance the role cancer genomics can play and is actively working towards increasing the awareness and understanding of CGP, staying true to Roche’s vision of continuously innovating diagnostics, shaping healthcare and
changing lives.
Hareeff Muhammed, CEO of Premier Integrated Labs, shared his enthusiasm for the partnership, highlighting their dedication to personalized medicine and unlocking the power of genetics for more precise treatments. Together with Roche, they aim to make CGP accessible to all patients, transcending socio-economic boundaries and geographic constraints.
Deepti Saraf, general manager of Roche (Malaysia) Sdn. Bhd., emphasized Roche’s commitment to evolving cancer care by personalizing treatments for each patient. She described the signing of the MoU as a significant milestone in Roche’s dedication to advancing healthcare in Malaysia and beyond.
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to improving lives through advancements in science. Roche’s combined strengths in pharmaceuticals and diagnostics, as well as data-driven medical insights, enable them to provide personalized healthcare.
